Regulatory  ·  2026-05-10

US explores FDA-style pre-release AI testing after Mythos capabilities alarm White House

RegulatoryHigh impactUnited States
The Trump administration is exploring mandatory pre-release safety testing for advanced AI models, similar to FDA drug approval processes, after Vice President JD Vance was reportedly 'alarmed' by Anthropic's Mythos model's ability to autonomously discover software vulnerabilities. National Economic Council Director Kevin Hassett stated the goal is to ensure AI systems 'are released to the wild after they've been proven safe,' with particular concern about models targeting critical infrastructure managed by local governments lacking disruption tools.
This represents a significant policy reversal for an administration that previously avoided linking 'safety' and 'AI' in the same sentence, according to Encode advocacy group. The shift from promoting AI innovation without constraint to considering binding pre-release requirements affects model deployment timelines, compliance costs, and the competitive landscape for frontier labs. The focus on local government infrastructure vulnerability is operationally relevant because it acknowledges AI-driven exploit development could compress time-to-exploitation toward zero for under-resourced targets.
Monitor White House announcements for details on the proposed testing framework, including which model capabilities trigger review, who conducts evaluations, timelines, and whether the regime applies only to US-developed models or also covers deployed foreign systems. Assess whether your organization's AI use cases involve critical infrastructure or autonomous vulnerability research, and prepare evidence of safety controls, monitoring, and human-in-the-loop governance if regulatory inquiries follow.
Sources
The Jerusalem Post
See this in the live feed Explore related AI security and governance findings — updated every morning.
Open the feed →